Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Lentiviral Gene Therapy for X-linked Severe Combined Immunodeficiency — Stella

Home/Severe Combined Immunodeficiency, X-Linked/

View on ClinicalTrials.gov

Recruiting

Back to Severe Combined Immunodeficiency, X-Linked trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United Kingdom

Great Ormond Street Hospital for Children NHS Foundation Trust, London, Greater London

Key details

Phase

Early testing

Sponsor

Great Ormond Street Hospital for Children NHS Foundation Trust

Enrollment target

~5 participants

Started

December 2018

Primary completion

August 2026

Age range

8 Weeks – 5 Years

Sex

Male only

Last updated October 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.